Genmab A/S (GMAB) PT Lowered to $30 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Yaron Werber lowered the price target on Genmab A/S (NASDAQ: GMAB) to $30.00 (from $32.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
